Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bio Key International (BKYI) Change in Receivables (2016 - 2025)

Bio Key International (BKYI) has disclosed Change in Receivables for 16 consecutive years, with -$24030.0 as the latest value for Q3 2025.

Quarterly Change in Receivables fell 105.11% to -$24030.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$432628.0 through Sep 2025, down 153.12% year-over-year, with the annual reading at -$25150.0 for FY2024, 105.87% down from the prior year.
Change in Receivables hit -$24030.0 in Q3 2025 for Bio Key International, up from -$69743.0 in the prior quarter.
In the past five years, Change in Receivables ranged from a high of $1.1 million in Q3 2021 to a low of -$895152.0 in Q2 2021.
Historically, Change in Receivables has averaged $74043.5 across 5 years, with a median of $19914.0 in 2024.
Biggest YoY gain for Change in Receivables was 4381.72% in 2021; the steepest drop was 5796.92% in 2021.
Year by year, Change in Receivables stood at -$370613.0 in 2021, then surged by 120.17% to $74748.0 in 2022, then surged by 456.1% to $415670.0 in 2023, then plummeted by 201.98% to -$423903.0 in 2024, then soared by 94.33% to -$24030.0 in 2025.
Business Quant data shows Change in Receivables for BKYI at -$24030.0 in Q3 2025, -$69743.0 in Q2 2025, and $85048.0 in Q1 2025.